STOK Archived Articles
Stoke Therapeutics (NASDAQ:STOK) Poised to Transform the Dravet Syndrome Treatment Landscape
Published on March 13, 2025
Stoke Therapeutics (NASDAQ:STOK): Pioneering RNA Medicine for Genetic Diseases
Published on November 30, 2024
Stoke Therapeutics, Inc. (NASDAQ:STOK): Restoring Protein Expression with RNA Therapeutics
Published on September 24, 2024